Damià Tormo

Dr. Tormo is the founder of Artax Biopharma and served as CEO. Prior, he was CEO of Bioncotech Therapeutics, a oncology clinical stage drug development company. Dr. Tormo has also founded biotech and healthcare investment firms including Biocapital Advisors, Restaura Biotech, Gentauris and Polymer Therapeutic Solutions. Dr. Tormo has been awarded important prizes related to innovation and entrepreneurship, including TR35 2011 from MIT and the Biogen Foundation award. Dr. Tormo is most recently a Partner with Columbus Venture Partners. In addition to Artax, Dr. Tormo currently serves on the boards of Bioncotech Therapeutics (Chairman), Polymer Therapeutic Solutions and Nubesis. Dr. Tormo holds a BSc from the University of Valencia, Spain, a PhD in Immunology and Molecular Genetics from the University of Bonn, Germany, and a master’s degree in biotechnology management (MBM) from IE Business School, Madrid.